Boston – The Bulfinch Companies, Inc., a commercial real estate and investment firm, announced the hiring of Colliers to lease 60 Hamilton Street, a lab and office property in Cambridge, MA.
The Colliers team representing Bulfinch includes Evan Gallagher, Executive Vice President; Curtis Cole, Executive Vice President; Nora Smith, Senior Advisor; and Jack Galvin, Advisor.
60 Hamilton Street is a two-story, 10,455 SF building ideally located in the heart of Cambridge near the MBTA Red Line, MIT and Harvard as well as Central and Kendall Square. This highly desirable lab or office space was built in 1925 and recently renovated in 2016, featuring brick and beam light-filled interiors that create a unique aesthetic with modern, move in ready design features. This amenity convenient location provides a variety of walkable options for tenants to enjoy. The property includes a bike rack area and showers and five on-site parking spaces as well as additional garage-parking options nearby.
“Our 60 Hamilton Street asset offers a first-class location, just steps from Cambridge shops, restaurants, MIT, and the Red Line ‘brain train’,” stated Mike Wilcox, SVP, Director of Leasing at Bulfinch, who is working with the Colliers team. “As we continue our longstanding relationship with Colliers, we will seek a tenant who can bring additional vibrancy to an already bustling Cambridge neighborhood.”
“Colliers is excited about the opportunity to once again work alongside Bulfinch to market their asset in the most active neighborhood in the region for biotech and high-tech demand,” stated Evan Gallagher, Executive Vice President of Colliers International.
60 Hamilton Street sits amidst a life science biotech hub adjacent to Kendall Square, and neighbors include Abbvie, Intellia Therapeutics, Fulcrum Therapeutics, SmartLabs, Acceleron, Agios, Blueprint Medicines, Takeda, and Sumitomo Dainippon Pharma Oncology.